Good morning. We all are looking forward to develo
Post# of 36537
The world needs a vaccine that is safe, works for most everyone and immunity lasts without having to have repeated doses assuming Covid-19 sticks around.
If we progress on this front and someone gets a good therapy for those who become ill, we can begin to get back to relative normal. GNBT can get the Excellagen sales back on track etc. Just as a reminder and for those newer posters, Excellagen sales were projected to be in the $200 million plus range per year. Obviously Covid-19 put that on pause. Fix Covid=fix GNBT revenue.